Affiliation:
1. Comfamiliar Risaralda
2. National University of Formosa
Abstract
Abstract
Background and aim
Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations in genes involved in chylomicron metabolism. On the other hand, multifactorial chylomicronemia syndrome (MCS) is a polygenic disorder and the most frequent cause of chylomicronemia, which results from the presence of multiple genetic variants related to chylomicron metabolism, in addition to secondary factors. However, their clinical, paraclinical, and molecular features are not well established in our country. The objective of this study was to describe the development and results of a screening program for severe hypertriglyceridemia in Colombia.
Methods
A cross-sectional study was performed. All patients aged > 18 years with triglyceride levels ≥ 500 mg/dL from 2010 to 2020 were included. The program was developed in three stages: 1. Review of electronic records and identification of suspected cases, based on laboratory findings (triglyceride levels ≥ 500 mg/dL); 2. Identification of suspected cases, based on laboratory findings that had no relevant secondary factors; 3. Probable cases were identified as having an FCS score ≥ 8 and performing genetic tests in probable cases with available samples.
Results
In total, we categorized 2415 patients as suspected clinical cases with a mean age of 53 years, of which 68% corresponded to male patients. The mean triglyceride levels were 705.37 mg/dL (standard deviation [SD] 335.9 mg/dL). After applying the FCS score, 2.4% of patients met the probable case definition, of which only 18 accepted molecular test. Additionally, 7 patients had unique variants in the APOA5 gene (c.694T > C; p.Ser232Pro) or in the GPIHBP1 gene (c.523G > C; p.Gly175Arg), for an apparent prevalence of familial chylomicronemia in the consulting population of 1,2 per 100.000 patients with TG measurement. No previously reported pathogenic variants were detected.
Conclusion
This study describes a screening program for the detection of severe hypertriglyceridemia. Although we identified seven patients as carriers of a variant in the APOA5 gene, we diagnosed only one patient with FCS. We believe that more programs of these characteristics should be developed in our region, given the importance of early detection of this metabolic disorder.
Publisher
Research Square Platform LLC
Reference35 articles.
1. Cepeda LL, Ramos-Garibay JA, Calderón DP, Reyes M. Xantomas eruptivos como manifestación inicial de diabetes mellitus e hipertrigliceridemia severa. 2010;19:4.
2. Terapia con insulina en pacientes con hipertrigliceridemia severa;Tamez-Pérez HE,2006
3. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management;Hegele RA;Lancet Diabetes Endocrinol,2014
4. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia;Virani SS;J Am Coll Cardiol,2021
5. Lizarzaburu Rodríguez V. Pancreatitis aguda por hipertrigliceridemia severa: reporte de caso y revisión de la literatura;Garavito Rentería J;Rev Gastroenterol Perú,2015